.omega.-[2-(tetrazolylalkyl)cyclohexyl]-2-aminoalkanoic acids as

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548253, A61K 3141, C07D25704

Patent

active

053310012

ABSTRACT:
The present invention pertains to antagonists of excitatory amino acid receptors, their method or preparation as well as compositions pertaining to them, which have the general formula: ##STR1## wherein R1 and R2 are selected from the group of hydrogen and C1 to C6 lower alkyl; the stereoisomers being in their resolved or racemic form; n and m are independently 0, 1, 2, or 3; and pharmaceutically acceptable salts thereof.

REFERENCES:
patent: 4657899 (1987-04-01), Rzeszotarski et al.
patent: 4761405 (1988-08-01), Rzeszotarski et al.
patent: 4822780 (1989-04-01), Tsuda et al.
patent: 4918064 (1990-04-01), Cordi et al.
patent: 5049555 (1991-09-01), Rzeszotarski et al.
Watkins et al., "Excitatory Amino Acid Transmitters," Amer. Rev. Pharmacol. Toxicol. (1981), vol. 21, pp. 165-204.
Schwarcz et al., "Quinolinic Acid: An Endogenous Metabolite that Produces Axon-Sparing Lesions in Rat Brain," Science, Jan. 1983, vol. 219, pp. 316-318.
Simon et al., "Blockade of N-Methyl-D-Aspartate Receptors May Protect Against Ischmeic Damage in the Brain," Science, vol. 226, pp. 850-852. (1983).
Foster et al., "Acidic Amino Acid Binding Sites in Mammalian Neuronal Membranes: Their Characteristics and Relationship to Synaptic Receptors," Brian Research Reviews, vol. 7, (1984), pp. 103-164.
Schoepp et al., "Pharamacological and Functional Characteristics of Metabotropic Excitatory Amio Acid Receptors," Tr. Pharmacol. Sci., Special Report (1991), pp. 74-81.
Faden et al., "Effects of Competitive and Non-Competitive NMDA Receptor Antagonists in Spinal Cord Injury," European Journal of Pharmacology, vol. 175 (1990), pp. 165-174.
Frandsen et al., "Direct Evidence that Excitotoxicity in Cultured Neurons is Mediated via N-Methyl-D-Aspartate (NMDA) as well as Non-NMDA Receptors," Journal of Neuro-Chemistry, vol. 53, No. 1, 1989, pp. 297-299.
Sheardown et al., "2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A Neuroprotectant for Cerebral Ischemia," Science, vol. 247, Feb. 1990, pp. 571-.
Costa, "Allosteric Modulatory Centers of Transmitter Amino Acid Receptors," Neuropsychopharmacology, vol. 2, No. 3, (1989), pp. 167-174.
Matoba et al., "Structural Modification of Bioactive Compounds. II. Syntheses of Aminophosphonoic Acid," Chem. Pharm. Bulletin, vol. 32 (1984), pp. 3918-3925.
Lodge et al., [Eds.], "The Pharmacology of Excitatory Amino Acids," Elsevier Trends Journal (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

.omega.-[2-(tetrazolylalkyl)cyclohexyl]-2-aminoalkanoic acids as does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .omega.-[2-(tetrazolylalkyl)cyclohexyl]-2-aminoalkanoic acids as, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .omega.-[2-(tetrazolylalkyl)cyclohexyl]-2-aminoalkanoic acids as will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-520283

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.